Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Does having HIV affect response to hepatitis C treatment?

A study from the US Veterans Health Administration found that HIV-positive people responded as well as those without HIV to direct-acting antiviral (DAA) therapy for hepatitis C,

Published
16 May 2016
By
Liz Highleyman
WHO issues new hepatitis C guidelines, EASL guidelines update forthcoming in September

In April, coinciding with the 2016 International Liver Congress in Barcelona, the World Health Organization (WHO) released an update to its Guidelines for the screening, care and treatment

Published
12 May 2016
By
Liz Highleyman
Philip Christopher Baldwin: “We need better access to treatment for gay men living with HIV and Hep C”

I am saddened by the delay in the provision of Hep C treatment in the UK. Of the 103,700 people living with HIV in the UK, nine per cent are co-infected with Hep C, many of them gay men. It is unfair that we have to cope with Hep C without help. We have a treatment which can cure Hep C, but the treatment is being withheld by the NHS for funding reasons.

Published
11 May 2016
From
Gay Times
Covering Costly HCV Tx: Who Makes that Call?

Forcing U.S. states to cover pricey treatments for people with the hepatitis C virus (HCV) would cause the Medicaid budget to "explode," according to a Medicaid representative.

Published
11 May 2016
From
MedPage Today HIV/AIDS
It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments

As consensus on the shortsightedness of insurance restrictions on life-saving hepatitis C treatments continues to build, it’s time for private insurers and Medicaid programs to give all Americans suffering from this devastating disease a chance at a cure.

Published
10 May 2016
From
American Journal of Managed Care
Study: Cheaper to cure hepatitis C sooner than later

Although it would take a huge investment at the outset, treating hepatitis C patients could save $800 billion in the next 20 years and free up treatment for thousands of people with other liver disease.

Published
10 May 2016
From
UPI.com
A Way Out of the Dismal Arithmetic of Hepatitis C Treatment

This special issue of The American Journal of Managed Care presents important new peer-reviewed research about the consequences of this dismal arithmetic of HCV treatment. The papers cover ground ranging from the out-of-pocket costs of a DAA treatment course to the real-world consequences—both economic and clinical—of failing to treat.

Published
10 May 2016
From
American Journal of Managed Care
Gilead's $1000 hepatitis C pill gets patent in India

In what could be a major setback to access to treatment in high-burden countries, the Indian Patent Office on Monday granted a patent to Gilead Pharmasset on Sovaldi (sofosbuvir), its blockbuster drug for hepatitis C, for which the company charges $1,000 per pill in the US.

Published
10 May 2016
From
Times of India
HCV associated with increased risk of cancers of the head and neck

Infection with hepatitis C virus (HCV) is associated with an increased risk of head and neck cancer (HNCs), investigators from the United States report in the Journal

Published
09 May 2016
By
Michael Carter
Hepatitis C kills more people than any other infectious disease in US, CDC says

The number of deaths due to hepatitis C is at an all-time high in the US and exceeds those attributable to 60 other infectious diseases including

Published
06 May 2016
By
Liz Highleyman

Filter by country